Skip to main content

Table 1 Patient’s demographic and clinical characteristics

From: Association of uncertain significance genetic variants with myocardial mechanics and morphometrics in patients with nonischemic dilated cardiomyopathy

Demographic and clinical variables

NIDCM group

(n = 95)

Age, years

49.7 ± 10.5

Male, n (%)

66 (69.5)

BMI, kg/m2

29.0 ± 5.8

Systolic blood pressure, mmHg

126.0 ± 13.3

Heart rate, bpm

79.1 ± 17.3

QRS duration, ms

119.1 ± 29.9

NYHA class, n (%)

I

II

III

IV

3 (3.2)

25 (26.3)

56 (58.9)

11 (11.6)

VT, n (%)

27 (28.4)

Cardiovascular risk factors, n (%)

Arterial hypertension

36 (37.9)

Dyslipidemia

45 (41.3)

Diabetes

8 (7.3)

Smoker

44 (40.4)

Obesity

70 (64.2)

AF

37 (38.9)

Pharmacotherapy (at baseline), n (%)

ACE-I/ARB

43 (39.4)

Betablocker

51 (46,7)

CCB

28 (25.6)

Aldosterone antagonist

9 (8.2)

Statins

20 (18.3)

Diuretic

3 (2.7)

Laboratory values

BNP, ng/l

1385.2 ± 986.9

TnI, ng/l

0.2 ± 0.3

hs-CRP, mg/l

3.0 ± 2.7

CRP, mg/l

9.0 ± 5.7

NLR

3.1 ± 3.0

ST2, pg/ml

49.9 ± 80.3

  1. ACE-I -angiotensin-converting enzyme inhibitor; AF - atrial fibrillation; ARB - angiotensin receptor blocker; BMI – body mass index; BNP – brain natriuretic peptide; CRP - C-reactive protein; Hs-CRP -high sensitivity C-reactive protein; LBBB – left bundle branch block; NIDCM - nonischemic dilated cardiomyopathy; NYHA – New York Heart Association; NLR - Neutrophil-to-lymphocyte ratio; ST2 - suppression of tumorigenicity 2 TnI – troponin I; VT - ventricular tachycardia